Evidence map›Paper›PMID 40081760›Full record

ArticleThe journal of allergy and clinical immunology. In practice2025

Skin testing improves predictive value of midrange peanut-specific IgE and Ara h 2 levels in the LEAP study.

Joshua S Bernstein, Thao Vu, Carolyn H Baloh, Michelle F Huffaker, George Du Toit, Stephen C Dreskin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of allergy and clinical immunology. In practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joshua S BernsteinDivision of Allergy and Clinical Immunology, Department of Medicine, University of Cincinnati, Cincinnati, Ohio. Electronic address: bernstj@ucmail.uc.edu.
Thao VuDepartment of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colo.
Carolyn H BalohDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital and Immune Tolerance Network, Boston, Mass.
Michelle F HuffakerImmune Tolerance Network, University of California San Francisco, San Francisco, Calif.
George Du ToitPeter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, London, UK; Pediatric Allergy Group, Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK; Children's Allergy Service, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Stephen C DreskinDivision of Allergy and Clinical Immunology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colo.

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nutsR01AI165866 · NIAID · UNIVERSITY OF COLORADO DENVER · PI STEPHEN C DRESKIN · 2021 to 2026
$4.2M
NIAID NIH HHS R01 AI165866NIAID NIH HHS UM1 AI109565
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40081760
PMCPMC12278761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.